While most patients with chronic myeloid leukemia (CML) express either e13a2 or e14a2 BCR-ABL1 transcripts, a significant minority expresses variant transcripts, of which e19a2 is the most common. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.